Multiple research fronts saw major advances on April 24, 2026, with AI models driving new capabilities in protein interaction prediction, automated protein design, and earthquake engineering ...
Merck KGaA plans to phase out most animal testing in favor of advanced human-relevant models, while OZMOSI and Planview are integrating structured clinical datasets with AI-driven R&D planning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results